CSL Behring is a global leader in the plasma protein biotherapeutics industry. The company researches, develops, manufactures and markets biotherapies used for the treatment of serious and rare conditions. CSL Behring’s commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything the company does. Whether it is manufacturing and marketing safe and effective products or researching and developing innovative biotherapies, it is first and foremost focused on fulfilling the customers’ needs.